期刊文献+

HPLC法测定人血浆中比阿培南的浓度 被引量:6

Determination of Biapenem in Human Plasma by HPLC
原文传递
导出
摘要 目的:建立以高效液相色谱法测定人血浆中比阿培南浓度的方法。方法:色谱柱为Hypersil ODS,流动相为乙腈-0.1mol.L-1乙酸钠缓冲液(2:98,pH4.38),流速为1.0mL.min-1,检测波长为300nm,柱温为25℃,进样量为20μL,样品温度为10℃。结果:比阿培南血药浓度在0.2~50μg.mL-1范围内线性关系良好(r=0.9997),最低检测限为0.2μg.mL-1。最低、低、中、高(0.2、0.5、5、50μg.mL-1)浓度血浆样品中的比阿培南的平均提取回收率分别为105.8%、91.5%、86.84%、97.00%,内标的平均回收率为97.04%;4种浓度的日内、日间RSD均<15%,均满足生物样品测定要求。结论:本方法简便、准确、快速、灵敏、专属性强、重现性高,可用于比阿培南人体药动研究。 OBJECTIVE: To establish an HPLC method for the determination of biapenem in human plasma. METHODS: Sample separation was conducted on Hypersil ODS chromatographic column; the mobile phase consisted of acetonitrile- 0.1 mol·L^-1 sodium acetate buffer solution (2 : 98,pH 4.38) at a flow rate of 1.0 mL·min^-1. The detection wavelength was set at ;300 nm; the column temperature was kept at 25℃ ;the sample size was 20μ and the sample temperature was kept at 10℃. RESULTS: Biapenem showed a good linear relation in the range of 0.2-50μg·mL^-1, with a lowest detectable limit of 0.2μg·mL^-1. The average recovery rates of biapenem at 4 different concentrations (0.2, 0.5, 5, 50μg·mL^-1) were 105.8%, 91.5%, 86.84% and 97.00%, respectively, and the average recovery rate of internal standard was 97.04%. Both the intra - day and inter- day RSD of the 4 concentrations of biapenem were less than 15%, all met the criteria for the determination of biological samples. CONCLUSION: The HPLC method is simple, accurate, rapid, sensitive, specific and reproducible, and it is applicable for the pharmacokinetic study of biapenem in human plasma.
出处 《中国药房》 CAS CSCD 北大核心 2009年第32期2517-2519,共3页 China Pharmacy
关键词 高效液相色谱法 比阿培南 血药浓度 HPLC Biapenem Plasma drug concentration
  • 相关文献

参考文献2

二级参考文献11

  • 1赵敏,赵国君,张勇.新碳青霉烯类抗生素比阿培南[J].中国临床药理学杂志,2005,21(5):390-392. 被引量:26
  • 2NAKASHIMA M, UEMATSU T, UENO K, et al. Phase Ⅰ study of L-627, biapenem, a new parenteral carbapenem antibiotic[J]. Int J Clin Pharmacol Ther Toxicol, 1993, 31(2): 70-76.
  • 3VESSILLIER S, DOCQUIER JD, RIVAL S, et al. Overproduction and biochemical characterization of the Chryseobacterium meningoseptieum BlaB metallo-beta-laetamase[J]. Antimierob Agents Chemother, 2002, 46(6): 1921-1927.
  • 4IKEDA K, IKAWA K, IKEDA A, et al. A simple and rapid determination of biapenem in plasma by high-performance liquid chromatography[J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2006, 844(1): 148-152.
  • 5Petersen P J, Jaeobus N V, Weiss W J, et al. In vitro and in vivo activities of LJC10, 627, a new carbapenem with stability to dehydropeptidase Ⅰ [J]. Antimicrob Agents Chemother, 1991,35(1) : 203-207.
  • 6Malanoski G J, Collins L, Wennersten C, et al. In vitro activity of biapenem against clinical isolates of Gram-positive and Gram-negative bacteria [J]. Antimicrob Agents Chemother,1993,37(9) :2009-2016.
  • 7Koeppe P, Hoeffler D, Fitzen B. Biapenem pharmacokinetics in healthy volunteers and in patients with impaired renal function [J]. Arzneimittel-Forschung, 1997,47(11):1250-1256.
  • 8Kozawa O, Uematsu T, Matsuno H, et al. Pharmacokinetics and safety of a new parenteral carbapenem antibiotic, biapenem (L-627), in elderly subjects [J]. Antimicrob Agents Chemother , 1998,42(6) : 1433-1436.
  • 9赵香兰.临床药代动力学[M].郑州:郑州大学出版社,2003年:113-187.
  • 10Nagashima S, Kozawa O, Otsuka T, et al. Pharmacokinetics of a parenteral carbapenem, biapenem, in patients with end-stage renal disease and influence of haemodialysis [J]. J Antimicrob Chemother , 2000,46 (5) :839-842.

共引文献22

同被引文献32

  • 1冯彦来,文爱东,金鑫,丁莉坤,杨林.HPLC法测定人血浆中比阿培南的浓度及其药动学研究[J].中国药房,2011,22(14):1288-1290. 被引量:3
  • 2赵敏,赵国君,张勇.新碳青霉烯类抗生素比阿培南[J].中国临床药理学杂志,2005,21(5):390-392. 被引量:26
  • 3张菁,邢亮彬.注射用比阿培南的含量测定方法研究[J].中国药业,2006,15(18):19-20. 被引量:6
  • 4Kozawa O, Uematsu T, Matsuno H, et al. Pharmacokinetics and safety of a new parenteral carbapenem antibiotic, biapenem (L-627), in elderly subjects [J]. Antimicrobial Agents and Chemotherapy,1998,42(6):1433- 1436.
  • 5Nagashima S, Kozawa O, Otsuka T, et al. Pharmacokineties of a parenteral carbapenem, biapenem, in patients with end-stage renal disease and influence of haemodialysis [J]. Antimicrob Chemother, 2000,46(5):839-842.
  • 6Nakashima M, Uematsu T, Ueno K, et al. Phase I study of L-627, biapenem, a new parenteral carbapenem antibiotic [J]. International Journal of Clinical Pharmacology:Therapy and Toxicology,1993,31:70- 76.
  • 7Knapp KM , English BK. Carbapenems [J ]. Setrnin Pediaw In [ect Dis, 2001, 12 (3): 175-185.
  • 8Xia M, Hang TJ, Zhang F, el al. The stability of biapenem and structural identification of impurities in aqueous solution[J].J Pharm Biomed Anal, 2009, 49 (4): 937-944.
  • 9Ikawa K, Morikawa N, Ikeda K, et al. Pharmacodynamic eval- uation of biapenem in peritoneal fluid using population pharma-cokinetic modelling and Monte Carlo simulation[J]. Int J Anti- microd Agents, 2008, 32 (4): 339-343.
  • 10Ikeda K, Ikawa K, Ikeda A, et al. A simple and rapid determi- nation of biapenem in plasma by high-performance liquid chro- matography [J]. J Chromatogr B, 2006, 844 (1): 148-152.

引证文献6

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部